Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare
Salarius Pharmaceuticals, Inc. Total Liabilities 2015–2022
Salarius Pharmaceuticals, Inc. annual total liabilities history from 2015 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Salarius Pharmaceuticals, Inc. total liabilities as of December 31, 2022: 4.3M, a 102.10% increase year-over-year.
- Salarius Pharmaceuticals, Inc. total liabilities for 2022 were 4.3M, a 102.10% increase from 2021.
- Salarius Pharmaceuticals, Inc. total liabilities for 2021 were 2.1M, a 23.88% decrease from 2020.
- Salarius Pharmaceuticals, Inc. total liabilities for 2020 were 2.8M, a 16.31% decrease from 2019.
- Salarius Pharmaceuticals, Inc. total liabilities for 2019 were 3.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Salarius Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $4 |
| 2021 | $2 |
| 2020 | $3 |
| 2019 | $3 |
| 2018 | $8 |
| 2017 | $6 |
| 2016 | $4 |
| 2015 | $3 |
Salarius Pharmaceuticals, Inc. Total Liabilities — FAQ
Salarius Pharmaceuticals, Inc. (DCOY) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DCOY's total liabilities history?
The chart and table above show Salarius Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.